Synthesis, biological evaluation, and structure-activity relationships of 2-[2-(benzoylamino)benzoylamino]benzoic acid analogues as inhibitors of adenovirus replication

Journal of Medicinal Chemistry

Volumn 55, Issue 7, 2012, Pages 3170-3181

  Öberg, Christopher T ^a   Strand, Mårten ^a   Andersson, Emma K ^a   Edlund, Karin ^a   Tran, Nam Phuong Nguyen ^a   Mei, Ya Fang ^a   Wadell, Göran ^a   Elofsson, Mikael ^a  

^a UMEÅ UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

2 [(3 BENZOYLAMINO)BENZOYLAMINO]BENZOIC ACID; 2 [(4 BENZOYLAMINO)BENZOYLAMINO]BENZOIC ACID; 2 [2 (2 FLUOROBENZOYLAMINO)BENZOYLAMINO] 4 CHLOROBENZOIC ACID; 2 [2 (2 FLUOROBENZOYLAMINO)BENZOYLAMINO] 5 CHLOROBENZOIC ACID; 2 [2 (2 FLUOROBENZOYLAMINO)BENZOYLAMINO]BENZOIC ACID; 2 [2 (3 FLUOROBENZOYLAMINO)BENZOYLAMINO]BENZOIC ACID; 2 [2 (4 CARBOXYBUTANOYLAMIDO)BENZOYL]AMINOBENZOIC ACID; 2 [2 (4 FLUOROBENZOYLAMINO)BENZOYLAMINO]BENZOIC ACID; 2 [2 (4 TOLUENESULFONYLAMINO)BENZOYLAMINO]BENZOIC ACID; 2 [2 (ACETYLAMINO)BENZOYLAMINO]BENZOIC ACID; 2 [2 (BENZOYLAMINO)BENZOYLAMINO]BENZENE; 2 [2 (BENZOYLAMINO)BENZOYLAMINO]BENZOIC ACID; 2 [2 (BENZOYLAMINO)BENZOYLAMINO]PHENYLACETIC ACID; 2 [2 (BENZOYLAMINO)PHENYLACETYLAMINO]BENZOIC ACID; 2 [2 (BENZYLAMINO)BENZOYLAMINO]BENZOIC ACID; 2 [2 (METHANESULFONYLAMINO)BENZOYLAMINO]BENZOIC ACID; 2 [2 (PHENYLACETYLAMINO)BENZOYLAMINO]BENZOIC ACID; 2 [2 (TRIMETHYLACETYLAMINO)BENZOYLAMINO]BENZOIC ACID; 2 [[2 (CYCLOHEXANECARBOXYLAMINO)BENZOYL]AMINO]BENZOIC ACID; 3 [(2 BENZOYLAMINO)BENZOYLAMINO]BENZOIC ACID; 4 [(2 BENZOYLAMINO)BENZOYLAMINO]BENZOIC ACID; ANTIVIRUS AGENT; BENZOIC ACID DERIVATIVE; CIDOFOVIR; ETHYL 2 [(2 BENZOYLAMINO)BENZOYLAMINO]BENZOATE; ETHYL 2 [(3 BENZOYLAMINO)BENZOYLAMINO]BENZOATE; ETHYL 2 [(4 BENZOYLAMINO)BENZOYLAMINO]BENZOATE; ETHYL 3 [(2 BENZOYLAMINO)BENZOYLAMINO]BENZOATE; ETHYL 4 [(2 BENZOYLAMINO)BENZOYLAMINO]BENZOATE; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ADENOVIRUS 5; ANTIVIRAL ACTIVITY; ARTICLE; CARBON NUCLEAR MAGNETIC RESONANCE; CONTROLLED STUDY; CYTOTOXICITY; DRUG DESIGN; DRUG EFFICACY; DRUG POTENCY; DRUG SCREENING; DRUG SYNTHESIS; ESTERIFICATION; NONHUMAN; PROTON NUCLEAR MAGNETIC RESONANCE; STRUCTURE ACTIVITY RELATION; VIRUS CELL INTERACTION; VIRUS INHIBITION; VIRUS REPLICATION;

ADENOVIRIDAE; ANTIVIRAL AGENTS; BENZAMIDES; BENZOIC ACIDS; CELL LINE, TUMOR; HUMANS; STRUCTURE-ACTIVITY RELATIONSHIP; VIRUS REPLICATION;

EID: 84859800238     PISSN: 00222623     EISSN: 15204804     Source Type: Journal    
DOI: 10.1021/jm201636v     Document Type: Article

References (31)

1. Antimicrob. Agents Chemother. 2010, 54, 3871
2. Andersson, E. K.; Strand, M.; Edlund, K.; Lindman, K.; Enquist, P. A.; Spjut, S.; Allard, A.; Elofsson, M.; Mei, Y. F.; Wadell, G. Small-molecule screening using a whole-cell viral replication reporter gene assay identifies 2-{[2-(benzoylamino)benzoyl]amino}-benzoic acid as a novel antiadenoviral compound Antimicrob. Agents Chemother. 2010, 54, 3871-3877
3. Wadell, G. Molecular epidemiology of human adenoviruses Curr. Top. Microbiol. 1984, 110, 191-220
4. Adrian, T. H.; Wadell, G.; Hierholzer, J. C.; Wigand, R. DNA restriction patterns of adenovirus prototypes 1 to 41 Arch. Virol. 1986, 91, 277-299
5. Wadell, G.; Allard, A.; Hierholzer, J. C. In Manual of Clinical Microbiology; 7th ed.; Murray, P. R.; Baron, E. J.; Pfaller, M. A.; Tenover; Yolken, R. H., Eds.; ASM Press: Washington, DC, 1999; pp 970-982.
6. Hierholzer, J. C. Adenoviruses in the immunocompromised host Clin. Microbiol. Rev. 1992, 5, 262-274
7. Klinger, J. R.; Sanchez, M. P.; Curtin, L. A.; Durkin, M.; Matyas, B. Multiple cases of life-threatening adenovirus pneumonia in a mental health care center Am. J. Resp. Crit. Care 1998, 157, 645-649
8. Baldwin, A.; Kingman, H.; Darville, M.; Foot, A. B. M.; Grier, D.; Cornish, J. M.; Goulden, N.; Oakhill, A.; Pamphilon, D. H.; Steward, C. G.; Marks, D. I. Outcome and clinical course of 100 patients with adenovirus infection following bone marrow transplantation Bone Marrow Transpl. 2000, 26, 1333-1338
9. Michaels, M. G.; Green, M.; Wald, E. R.; Starzl, T. E. Adenovirus infection in pediatric liver transplant recipients J. Infect. Dis. 1992, 165, 170-172
10. Kojaoghlanian, T.; Flomenberg, P.; Horwitz, M. S. The impact of adenovirus infection on the immunocompromised host Rev. Med. Virol. 2003, 13, 155-171
11. Kroes, A. C. M.; de Klerk, E. P. A; Lankester, A. C.; Malipaard, C.; de Brouwer, C. S.; Claas, E. C. J.; Jol-van der Zijde, E. C.; van Tol, M. J. D. Sequential emergence of multiple adenovirus serotypes after pediatric stem cell transplantation J. Clin. Virol. 2007, 38, 341-347
12. Leruez-Ville, M.; Chardin-Ouachee, M.; Neven, B.; Picard, C.; Le Guinche, I.; Fischer, A.; Rouzioux, C.; Blanche, S. Description of an adenovirus A31 outbreak in a paediatric haematology unit Bone Marrow Transpl. 2006, 38, 23-28
13. Muller, W. J.; Levin, M. J.; Shin, Y. K.; Robinson, C.; Quinones, R.; Malcolm, J.; Hild, E.; Gao, D.; Giller, R. Clinical and in vitro evaluation of cidofovir for treatment of adenovirus infection in pediatric hematopoietic stem cell transplant recipients Clin. Infect. Dis. 2005, 41, 1812-1816
14. Hoffman, J. A.; Shah, A. J.; Ross, L. A.; Kapoor, N. Adenoviral infections and a prospective trial of cidofovir in pediatric hematopoietic stem cell transplantation Biol. Blood Marrow Transplant. 2001, 7, 388-394
15. Naesens, L.; Lenaerts, L.; Andrei, G.; Snoeck, R.; Van Beers, D.; Holy, A.; Balzarini, J.; De Clercq, E. Antiadenovirus activities of several classes of nucleoside and nucleotide analogues Antimicrob. Agents Chemother. 2005, 49, 1010-1016
16. Gavin, P. J.; Katz, B. Z. Intravenous ribavirin treatment for severe adenovirus disease in immunocompromised children Pediatrics 2002, 110, e9
17. Bordigoni, P.; Carret, A.-S.; Venard, V.; Witz, F.; Le Faou, A. Treatment of adenovirus infections in patients undergoing allogeneic hematopoietic stem cell transplantation Clin. Infect. Dis. 2001, 32, 1290-1297
18. Lion, T.; Kosulin, K.; Landlinger, C.; Rauch, M.; Preuner, S.; Jugovic, D.; Pötschger, U.; Lawitschka, A.; Peters, C.; Fritsch, G.; Matthes-Martin, S. Monitoring of adenovirus load in stool by real-time PCR permits early detection of impending invasive infection in patients after allogeneic stem cell transplantation Leukemia 2010, 24, 706-714
19. Ueki, M.; Amemiya, M. Removal of 9-fluorenylmethyloxycarbonyl (Fmoc) group with tetrabutylammonium fluoride Tetrahedron Lett. 1987, 28, 6617-6620
20. 2) and its application to gas-chromatographic analysis of fatty acids Chem. Pharm. Bull. 1981, 29, 1475-1478
21. Eastwood, A. L.; Blum, A. P.; Zacharias, N. M.; Dougherty, D. A. A selenide-based approach to photochemical cleavage of peptide and protein backbones at engineered backbone esters J. Org. Chem. 2009, 74, 9241-9244
22. Cao, S.; Hernandez-Matéo, F.; Roy, R. Scope and applications of active and latent thioglycosyl donors. Part 4 J. Carbohydr. Chem. 1998, 17, 609-631
23. Kauppi, A. M.; Andersson, C. D.; Norberg, H. A.; Sundin, C.; Linusson, A.; Elofsson, M. Inhibitors of type III secretion in Yersinia: design, synthesis and multivariate QSAR of 2-arylsulfonylamino-benzanilides Bioorg. Med. Chem. 2007, 15, 6994-7011
24. Gowda, S.; Gowda, B. K. K.; Gowda, D. C. Hydrazinium monoformate: a new hydrogen donor. Selective reduction of nitrocompounds catalyzed by commercial zinc dust Synth. Commun. 2003, 33, 281-289
25. Larsen, J. W.; Freund, M.; Kim, K. Y.; Sidovar, M.; Stuart, J. L. Mechanism of the carbon catalyzed reduction of nitrobenzene by hydrazine Carbon 2000, 38, 655-661
26. Roehm, N. W.; Rodgers, G. H.; Hatfield, S. M.; Glasebrook, A. L. An improved colorimetric assay for cell proliferation and viability utilizing the tetrazolium salt XTT J. Immunol. Methods 1991, 142, 257-265
27. Scudiero, D. A.; Shoemaker, R. H.; Paull, K. D.; Monks, A.; Tierney, S.; Nofziger, T. H.; Currens, M. J.; Seniff, D.; Boyd, M. R. Evaluation of a soluble tetrazolium/formazan assay for cell growth and drug sensitivity in culture using human and other tumor cell lines Cancer Res. 1988, 48, 4827-4833
28. Weislow, O. S.; Kiser, R.; Fine, D. L.; Bader, J.; Shoemaker, R. H.; Boyd, M. R. new soluble-formazan assay for HIV-1 cytopathic effects: application to high-flux screening of synthetic and natural products for AIDS-antiviral activity J. Natl. Cancer Inst. 1989, 81, 577-586
29. Heid, C. A.; Stevens, J.; Livak, K. J.; Williams, P. M. Real time quantitative PCR Genome Res. 1996, 6, 986-994
30. Allard, A.; Albinsson, B.; Wadell, G. Rapid typing of human adenoviruses by a general PCR combined with restriction endonuclease analysis J. Clin. Microbiol. 2001, 39, 498-505
31. Hernroth, B. E.; Conden-Hansson, A. C.; Rehnstam-Holm, A. S.; Girones, R.; Allard, A. K. Environmental factors influencing human viral pathogens and their potential indicator organisms in the blue mussel, Mytilus edulis: the first Scandinavian report Appl. Environ. Microbiol. 2002, 68, 4523-4533